Julian Chick
Chairman at CANN GROUP LIMITED
Julian Chick active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CANN GROUP LIMITED | Chairman | 28/08/2023 | - |
| Director/Board Member | 26/10/2022 | 28/08/2023 | |
| LTR PHARMA LIMITED | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
Mid-Atlantic BioTherapeutics, Inc.
 Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | - | - |
Career history of Julian Chick
Former positions of Julian Chick
| Companies | Position | Start | End |
|---|---|---|---|
| OPYL LIMITED | Director/Board Member | 16/09/2022 | 13/02/2023 |
| Chairman | 06/05/2019 | 16/09/2022 | |
| Investor Relations Contact | 06/05/2019 | 13/02/2023 | |
| TALI DIGITAL LIMITED | Director/Board Member | 07/09/2004 | 31/05/2010 |
| Chief Executive Officer | 07/09/2004 | 31/05/2010 | |
| ANTERIS TECHNOLOGIES LTD | Director/Board Member | 07/12/2011 | - |
| Chief Operating Officer | 07/12/2011 | - |
Training of Julian Chick
| University of Oxford | Doctorate Degree |
| LaTrobe University | Undergraduate Degree |
Statistics
International
| Australia | 7 |
| United Kingdom | 2 |
| United States | 2 |
Operational
| Director/Board Member | 6 |
| Chairman | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Technology Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| TALI DIGITAL LIMITED | Technology Services |
| ANTERIS TECHNOLOGIES LTD | Health Technology |
| OPYL LIMITED | Technology Services |
| CANN GROUP LIMITED | Process Industries |
| LTR PHARMA LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Commercial Services |
- Stock Market
- Insiders
- Julian Chick
- Experience
